Patents by Inventor William Glen Harter

William Glen Harter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Androgen modulators
    Patent number: 7670613
    Abstract: The present invention is directed to a new class of 4-cycloalkoxy benzonitriles and to their use as androgen receptor modulators. Other aspects of the invention are directed to the use of these compounds to decrease excess sebum secretions and to stimulate hair growth.
    Type: Grant
    Filed: July 5, 2005
    Date of Patent: March 2, 2010
    Assignee: Pfizer Inc.
    Inventors: Lain-Yen Hu, Bruce A. Lefker, Daniel Y. Du, Yvonne Dorothy Smith, Huangshu Lei, William Glen Harter, Victoria Leigh Downs, Mark L. Boys, Donna Michele Iula
  • ANDROGEN MODULATORS
    Publication number: 20100048517
    Abstract: The present invention is directed to a new class of 4-cycloalkoxy benzonitriles and to their use as androgen receptor modulators. Other aspects of the invention are directed to the use of these compounds to decrease excess sebum secretions and to stimulate hair growth.
    Type: Application
    Filed: November 5, 2009
    Publication date: February 25, 2010
    Inventors: Lain-Yen Hu, Bruce A. Lefker, Daniel Y. Du, Yvonne Dorothy Smith, Huangshu Lei, William Glen Harter, Victoria Leigh Downs, Mark L. Boys, Donna Michele Iula
  • ANDROGEN MODULATORS
    Publication number: 20090170886
    Abstract: The present invention is directed to a new class of benzonitriles and to their use as androgen receptor modulators. Other aspects of the invention are directed to the use of these compounds to decrease excess sebum secretions and to stimulate hair growth.
    Type: Application
    Filed: July 7, 2006
    Publication date: July 2, 2009
    Inventors: Mark Laurence Boys, Michelle Marie Bruendl, Victoria Leigh Downs, Stephen Alan Fakhoury, William Glen Harter, Lain-Yen Hu, Sandra Marie Jennings, Bruce Allen Lefker, Lorna Helen Mitchell, Raj Kumar Raheja, Yvonne Dorothy Smith
  • Phenylene alkyne matrix metalloproteinase inhibitors
    Patent number: 6849648
    Abstract: A compound of Formula I or a pharmaceutically acceptable salt thereof, or a tautomer thereof, wherein G1, G2, and B are as defined in the application, are selective inhibitors of MMP-13. The compounds are useful for treating diseases mediated by MMP-13, including cancer and arthritis.
    Type: Grant
    Filed: October 4, 2002
    Date of Patent: February 1, 2005
    Assignee: Warner-Lambert Company
    Inventors: Amy Mae Bunker, William Glen Harter, James Lester Hicks, Patrick Michael O'Brien, Ly Pham, Joseph Armand Picard, William Howard Roark
  • Alkyne matrix metalloproteinase inhibitors
    Publication number: 20030144274
    Abstract: A compound of Formula I 1
    Type: Application
    Filed: October 4, 2002
    Publication date: July 31, 2003
    Inventors: Amy Mae Bunker, William Glen Harter, James Lester Hicks, Patrick Michael O'Brien, Ly Pham, Joseph Armand Picard, William Howard Roark
  • Fused pyrimidinone matrix metalloproteinase inhibitors
    Publication number: 20030004172
    Abstract: Selective MMP-13 inhibitors are fused pyrimidinones of the formula 1
    Type: Application
    Filed: February 13, 2002
    Publication date: January 2, 2003
    Inventors: William Glen Harter, Jie Jack Li, Daniel Fred Ortwine, Kevon Ray Shuler, Wen-Song Yue
  • Sulfonamide interleukin-1beta converting enzyme inhibitors
    Publication number: 20020156094
    Abstract: The present invention relates to compounds that are inhibitors of interleukin-1&bgr; converting enzyme that have the Formula (I). This invention also relates to a method of treatment of stroke, reperfusion injury, Alzheimer's disease, shigellosis, inflammatory diseases, and septic shock and to a pharmaceutically acceptable composition that contains a compound that is an inhibitor of interleukin-1&bgr; converting enzyme.
    Type: Application
    Filed: September 25, 2001
    Publication date: October 24, 2002
    Applicant: Warner-Lambert Company
    Inventors: Hans P. Albrecht, Hamish John Allen, Kenneth Dale Brady, William Glen Harter, Catherine Rose Kostlan, Bruce David Roth, Nigel Walker
  • Sulfonamide interleukin-1&bgr; converting enzyme inhibitors
    Patent number: 6316415
    Abstract: The present invention relates to compounds that are inhibitors of interleukin-1&bgr; converting enzyme that have the Formula (I). This invention also relates to a method of treatment of stroke, reperfusion injury, Alzheimer's disease, shigellosis, inflammatory diseases, and septic shock and to a pharmaceutically acceptable composition that contains a compound that is an inhibitor of interleukin-1&bgr; converting enzyme.
    Type: Grant
    Filed: April 9, 1999
    Date of Patent: November 13, 2001
    Assignees: BASF Aktiengesellschaft, Warner-Lambert Company
    Inventors: Hans P. Albrecht, Hamish John Allen, Kenneth Dale Brady, William Glen Harter, Catherine Rose Kostlan, Bruce David Roth, Nigel Walker
  • Sulfonamide substituted aspartic acid interleukin-1.beta. converting enzyme inhibitors
    Patent number: 6083981
    Abstract: The present invention relates to compounds that are inhibitors of interleukin-1.beta. converting enzyme that have the Formula I, II, or III. ##STR1## This invention also relates to a method of treatment of stroke, inflammatory diseases, septic shock reperfusion injury, Alzheimer's disease, and shigellosis, and to a pharmaceutically acceptable composition that contains a compound that is an inhibitor of interleukin-1.beta. converting enzyme.
    Type: Grant
    Filed: April 9, 1999
    Date of Patent: July 4, 2000
    Assignee: Warner-Lambert Company
    Inventors: Hamish John Allen, Kenneth Dale Brady, William Glen Harter, Elizabeth Ann Lunney, Mark Stephen Plummer, Tomi Sawyer, Aurash Shahripour, Nigel Walker